Unraveling the hepatoprotective and anti-pancreatic cancer potential of Caralluma europaea: a comprehensive in vivo, in vitro and in silico evidence
Fatima Ez-zahra Amrati Adrian Lim Meryem Slighoua Mohamed Chebaibi Ibrahim Mssillou Aziz Drioiche Francesca Di Cristo Yazeed A. Al-Sheikh Mourad A. M. Aboul-Soud Mouad Edderkaoui Dalila Bousta a Laboratory of Cell Biology and Molecular Genetics (LBCGM),Department of Biology,Faculty of Sciences,Ibn Zohr University,Agadir,Souss Massa,Moroccob Departments of Medicine and Biomedical Sciences,Samuel Oschin Comprehensive Cancer Center,Cedars-Sinai Medical Center,Los Angeles,CA,USAc Laboratory of Biotechnology,Environment,Agri-Food,and Health (LBEAS),Faculty of Sciences,University Sidi-Mohamed-Ben-Abdellah (USMBA),Fez,Moroccod Ministry of Health and Social Protection,Higher Institute of Nursing Professions and Health Techniques,Marrakech,Moroccoe Ministry of Health and Social Protection,Higher Institute of Nursing Professions and Health Techniques,Fez,Moroccof Biomedical and Translational Research Laboratory,Faculty of Medicine and Pharmacy of the Fez,University of Sidi Mohamed Ben Abdellah,Fez,Moroccog Laboratory of Natural Substances,Pharmacology,Environment,Modeling,Health & Quality of Life (SNAMOPEQ),Faculty of Sciences Dhar El Mahraz,Sidi Mohamed Ben Abdellah University,Fez,Moroccoh Laboratory of Innovative Materials and Biotechnology of Natural Resources,Faculty of Sciences,Moulay Ismail University,Meknes,Moroccoi Research Institute on Terrestrial Ecosystems (IRET),National Research Council,Porano,Italyj Department of Clinical Laboratory Sciences,College of Applied Medical Sciences,King Saud University,Riyadh,Saudi Arabiak Department of Medicine,University of California at Los Angeles,Los Angeles,CA,USAl National Agency of Medicinal and Aromatic Plants,Taounate,Morocco
DOI: https://doi.org/10.1080/01480545.2024.2402430
2024-10-18
Drug and Chemical Toxicology
Abstract:Caralluma europaea Guss. ( C. europaea ) is a medicinal plant used for cancer treatment. However, these treatments may be associated with complications that need to be investigated. This work aims to evaluate not only the chemical composition but also the hepatoprotective and anticancer properties of C. europaea extracts. The chemical constitution of the hydroethanolic extract was explored using gas chromatography-mass spectrometry (GC-MS) and high-performance liquid chromatography (HPLC). The hydroethanolic extract, flavonoids, and polyphenols-rich extract at 100, 15, and 50 mg/kg, respectively, were administered to acetaminophen-treated rats for seven days. We used Western blotting and Real-Time quantitative Polymerase Chain Reaction (RT-qPCR) to determine the protein and the mRNA levels of cancer stemness markers in pancreatic cancer cell lines MIA PaCa-2 and BxPC-3 exposed to increasing doses of C. europaea extracts. In silico analysis was used to evaluate the effects of phenolic compounds revealed in C. europaea on caspase-3 and HSP90, and on liver damage on CYP2E1. The primary phenolics detected by GC-MS and HPLC were ferulic acid and benzofurazan. The positive control group showed an increase in AST, ALT, ALP, triglycerides, and VLDL levels. C. europaea extracts demonstrated hepatoprotective effects by ameliorating acetaminophen-induced alterations of biochemical and hispathological parameters. Immunoblotting and RT-qPCR profiling of cancer stemness markers indicated a reduction in the expression levels of Oct-4 and Nanog proteins, as well as a reduction in the mRNA levels of CD133 by 50–60% and Sox2 by 80–90% in pancreatic cancer cells. Molecular docking showed that naringenin presented the highest docking Gscore on CYP2E1 (−8.199) and HSP90 (−7.742). In conclusion, C. europaea extracts could be considered as a safe and promising therapeutic strategy to sensitize pancreatic cancer cells to chemotherapy.
pharmacology & pharmacy,toxicology,chemistry, multidisciplinary